Quest Diagnostics
DGX
$133.77
Share price
0.81%
Change (1 day)
-7.99%
Change (1 year)
Categories
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.
Quest Diagnostics (DGX) - Net assets
Net assets on the balance sheet as of March 2023 : $6.16 B
According to Quest Diagnostics
's latest financial reports the company has $6.16 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Quest Diagnostics - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $6.00 B | -8.46% |
| 2021-12-31 | $6.56 B | -4.77% |
| 2020-12-31 | $6.89 B | 19.57% |
| 2019-12-31 | $5.76 B | 7.84% |
| 2018-12-31 | $5.34 B | 6.14% |
| 2017-12-31 | $5.03 B | 6.29% |
| 2016-12-31 | $4.73 B | -0.96% |
| 2015-12-31 | $4.78 B | 10.46% |
| 2014-12-31 | $4.33 B | 8.99% |
| 2013-12-31 | $3.97 B | -5.08% |
| 2012-12-31 | $4.18 B | 12.67% |
| 2011-12-31 | $3.71 B | -8.36% |
| 2010-12-31 | $4.05 B | 1.06% |
| 2009-12-31 | $4.01 B | 11.28% |
| 2008-12-31 | $3.60 B | 8.44% |
| 2007-12-31 | $3.32 B | 10.1% |
| 2006-12-31 | $3.01 B | 9.27% |
| 2005-12-31 | $2.76 B | 20.73% |
| 2004-12-31 | $2.28 B | -4.43% |
| 2003-12-31 | $2.39 B | 35.38% |
| 2002-12-31 | $1.76 B | 32.4% |
| 2001-12-31 | $1.33 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 LabCorp LH | $10.36 B | 68.06% | 🇺🇸 USA |
 Psychemedics PMD | $10.77 M | -99.83% | 🇺🇸 USA |
 NeoGenomics
NEO | $0.99 B | -83.81% | 🇺🇸 USA |
 Qiagen QGEN | $3.46 B | -43.77% | 🇳🇱 Netherlands |
 Enzo Biochem ENZ | $32.83 M | -99.47% | 🇺🇸 USA |